References
- Fuchs-Tarlovsky V, Barbosa V, Mendoza J, Vargas A, Amancio O, et al.: Evaluación del impacto de un tratamiento nutricional intensivo sobre el estado nutricional de pacientes con cáncer de cabeza y cuello en estadio III y IV. Nutr Hosp 23, 134–140, 2008.
- Seelaender M, Batista-Junior M, Lira F, Silverio R, and Rossi-Fanelli F: Inflammation in cancer cachexia: To resolve or not to resolve (is that the question?). Clin Nutrition 31, 562–566, 2012. doi: 10.1016/j.clnu.2012.01.011.
- García-Luna PP, Parejo JC, Aliaga AV, Pachón JI, Serrano SA, et al.: Nutrición y cáncer. Nutr Hosp Suplementos 5(1), 17–32, 2012.
- Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83, 1345–1350, 2006. doi:10.1093/ajcn/83.6.1345.
- Tuca AR, Calsina-Berna A, González-Barboteo J and Gómez-Batiste XA: Caquexia en cáncer. Med Clin (Barc) 135(12), 568–572, 2010. doi:10.1016/j.medcli.2010.06.003.
- Maciejewski B, Sklandowski K, Pilecki B, Taylor JM, Withers RH, et al.: Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 40, 137–145, 1996. doi:10.1016/0167-8140(96)01776-8.
- Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, et al.: Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66, 253–262, 2003. doi:10.1016/S0167-8140(02)00404-8.
- Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, et al.: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 19, 567–575, 1997. doi:10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5.
- Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12(5), 489–495, 2011. doi:10.1016/S1470-2045(10)70218-7.
- Fearon KC: Cancer Cachexia and Fat–Muscle Physiology. N Engl J Med 365, 6, 2011. doi:10.1056/NEJMcibr1106880.
- Tisdale MJ: Mechanisms of Cancer Cachexia. Physiol Rev. 89, 381–410, 2009. doi:10.1152/physrev.00016.2008.
- Douglas WG, Lahart I, Amtul RC, Yianis KT, Metsios GS, et al.: Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 4, 111–124, 2013. doi:10.1007/s13539-012-0096-0.
- Rodrigo Valenzuela B, Karla Bascuñan G, Rodrigo Chamorro M, and Alfonso Valenzuela B: Omega-3 fatty acids and cancer, a nutritional alternative for its prevention and treatment. Rev Chil Nutr 38(2), 219–226, 2011. doi:10.4067/S0717-75182011000200012.
- Rodrigo Valenzuela B, Gladys Tapia O, Marcela González E, and Alfonso Valenzuela B: Omega-3 fatty acids (EPA and DHA) and its application in diverse clinical situations. Rev Chil Nutr 38(3), 356–367, 2011. doi:10.4067/S0717-75182011000300011.
- Rodríguez-Cruz M, Tovar AR, Del-Prado M, and Torres N: Mecanismos moleculares de acción de los ácidos grasos poliinsaturados y sus beneficios en la salud. Rev Invest Clin 57(3), 457–472, 2005.
- Gogus A, and Smith C: n-3 Omega fatty acids: a review of current knowledge. Int J Food Sci Technol 45, 417–436, 2010. doi:10.1111/j.1365-2621.2009.02151.x.
- Lorgeril M and Salen P: New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. de Lorgeril and Salen BMC Med 10, 50, 2012. doi: 10.1186/1741-7015-10-50.
- Harle L, Brown T, Laheru D, and Dobs AS: Omega-3 Fatty Acids for the Treatment of Cancer Cachexia: Issues in Designing Clinical Trials of Dietary Supplements. J Alter Complement Med 11(6), 1039–1046, 2005. doi:10.1089/acm.2005.11.1039.
- Colomer R, Moreno-Nogueira JM, García-Luna PP, García- Peris P, García de Lorenzo A, et al.: N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97, 823–31, 2007. doi:10.1017/S000711450765795X.
- Ries A, Trottenberg P, Elsner F, Stiel S, Haugen D, et al.: A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project. Palliative Med 26(4), 294–304, 2012. doi: 10.1177/0269216311418709.
- Pérez-Lizaur AB, Palacios-González B, Castro-Becerra AL and and Flores-Galicia I: SMAO: Sistema Mexicano de Alimentos Equivalentes. Fourth edition, Editorial Ogali, Ciudad de Mexico, 2014.
- Thompson KL, Elliott L, Fuchs-Tarlovsky V, Levin RM, Voss AC and Piemonte T. Oncology evidence-based nutrition practice guideline for adults. J Acad Nutr Diet 117, 297–310, 2017. doi:10.1016/j.jand.2016.05.010.
- Wong B Enríquez A, and Barrera R: Nutrition support in critically ill patients with cancer. Oncol Critical Care 17(3), 743–767, 2001.
- Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al.: ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 36, 11–48, 2017. doi:10.1016/j.clnu.2016.07.015.
- Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, et al.: EORTC QLQ-C30 Scoring Manual (3rd edition). EORTC, Belguim, 2001. ISBN: 2-9300 64-22-6.
- Shimura SY, Neves RXD, Rosa-Neto JC, Dos-Santos FL, Batista-Jr ML, et al.: White adipose tissue IFN-c expression and signalling along the progression of rodent cancer cachexia. Cytokine 89, 122–126, 2017. doi:10.1016/j.cyto.2016.02.015.
- Bien E, Balcerska A, Adamkiewicz-Drozynska E, Rapala M, Krawczyk M, et al.: Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias. Clin Biochem 42, 1144–1157, 2009. doi:10.1016/j.clinbiochem.2009.04.004.
- De Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC: A Randomized Clinical Trial with Oral Immunonutrition (3-Enhanced Formula vs. Arginine-Enhanced Formula) in Ambulatory Head and Neck Cancer Patients. Ann Nutr Metab 49, 95–99, 2005. doi:10.1159/000084742.
- De Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC, et al.: A randomized clinical trial with two omega 3 fatty acid enhanced oral suplements in head and neck cancer ambulatory patients. Europ Rev Med Pharmacol Sci 12, 177–181, 2008.
- De Luis DA, Izaola O, Cuellar L, Terroba MC, Ventosa M, et al.: Clinical effects of a w3 enhanced powdered nutritional formula in postsurgical ambulatory head and neck cancer patients. Nutr Hosp. 28(5), 1463–1467, 2013. doi:10.3305/nh.2013.28.5.6662.
- Weed HG, Ferguson ML, Gaff RL, Hustead DS, Nelson JL, et al.: Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid. Head Neck. 33(7), 1027–1033, 2011. doi:10.1002/hed.21580.
- Correira-Pereira MA, Santos CA, Almeida-Brito J and Fonseca J: Scored patient-generated subjective global assessment, albumin and transferrin for nutritional assessment of gastrostomy fed head or neck cancer patients. Nutr Hosp. 29(2), 420–426, 2014. doi:10.3305/nh.2014.29.2.7066.
- Marín-Caro MM, Laviano A, Pichard C and Gómez-Candela C: Relación entre la intervención nutricional y la calidad de vida en el paciente con cáncer. Nutr Hosp. 22(3), 337–350, 2007.